We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA WARNS KOS ABOUT QUALITY SYSTEM DEFICIENCIES
FDA WARNS KOS ABOUT QUALITY SYSTEM DEFICIENCIES
January 13, 2004
The FDA has sent Kos Pharmaceuticals a warning letter citing quality system deficiencies observed during an inspection of the drugmaker's main manufacturing facility, the company announced Monday.